News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News Quality Containers Expands Into Tampa Bay, Following Nationwide Growth News Transportvibe Search Data Shows Auto Transport Reviews Draw More Interest Than Pricing Pages News Metaguest Congratulates Henry Tang on New Leadership Role with Hypersonica News Neptune Highlights SpaceX Liquidity and Derivative Strategy, Provides Treasury Update News ApprovalMax Launches Pay in the US as UK Payments near £100 Million News Designli Earns Multiple Industry Recognitions for App and Software Development in 2026
